Asianet Newsable on MSN
How Merck is preparing for the patent cliff of its blockbuster cancer drug Keytruda
Scotiabank lifted its Merck target to $136 and kept an ‘Outperform’ rating, implying a 17% upside.
Investing.com -- Novartis AG (SIX: NOVN) on Wednesday forecast low single-digit sales growth for 2026 and said core operating income would decline by a similar margin, as the Swiss pharmaceutical ...
Opinion
Exemption of BCD too narrow & indirect measure to impact out-of-pocket expenses: Advocacy group
Exemption of BCD too narrow & indirect measure to impact out-of-pocket expenses: Advocacy group: Our Bureau, New Delhi Wednesday, February 4, 2026, 08:00 Hrs [IST] The patient adv ...
Reduced reciprocal tariffs should provide cheer to Indian exporters, but the deal will remain predictable only as long as ...
Apple may be gearing up for a landmark shift in iPhone battery technology - one that could finally close the long-standing ...
Harrity Patent Analytics is proud to announce the release of the 2026 Patent 300® Report. This annual report ranks the top 300 companies, organizations, and universities based on the total number of U ...
Sony has filed what might very well be one of its worst patents ever. It’s titled ‘LLM-Based Generative Podcasts for Gamers’ ...
A Kansas federal judge has fined lawyers representing a patent holding company a combined $12,000 for filing documents with ...
Without a governed control infrastructure layer, continuous AI‑driven preventive care will fail at scale due to unsafe interventions, reimbursement fa ...
A new patent registered by Sony suggests the company is exploring the idea of personalized podcasts on PS5, hosted by ...
A Sony patent indicates that AI-generated podcasts tailored to individual players could be on the way, and they may feature PlayStation characters.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results